Načítá se...
RARE-05. ARE TRANSGENDER INDIVIDUALS STRONGLY PREDISPOSED TO DEVELOPMENT OF PROLACTINOMAS?
Transgender individuals usually receive long-term hormone treatment in the course of their sexual transition. Although the effects of this on possible development of neoplasia are largely unknown, very limited literature has suggested they may be predisposed to development of prolactinomas. We queri...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847521/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.928 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|